Editorial sharply condemning Robert F. Kennedy Jr.’s first year serving as United States Secretary of Health and Human Services (HHS).
- Ian Miller
- 2 hours ago
- 6 min read
In late February/early March 2026, The Lancet, one of the world’s oldest and most prestigious medical journals, broke from convention and published an exceptionally blunt editorial condemning the first year of Robert F. Kennedy Jr.’s tenure leading the U.S.
Department of Health and Human Services. Rather than offering modest concerns or tempered caution, the editors issued a stark warning: “the destruction that Kennedy has wrought in 1 year might take generations to repair.” This wording was extraordinary not just for its strength but because major scientific journals rarely deploy such plainspoken denunciations of a sitting government official.
The criticism reflects not merely disagreements over specific policies but what The Lancet sees as a fundamental shift away from evidence‑based public health and scientific norms within the largest health bureaucracy in the world. HHS oversees agencies such as the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services (CMS) — collectively responsible for everything from disease surveillance and vaccine recommendations to drug approvals and biomedical research.
When Kennedy was confirmed as HHS Secretary in February 2025, he promised a new era marked by “radical transparency, gold‑standard science, ethics, compassion, competency, and a restoration of trust in public health institutions.” He pledged that agency decisions would be open to public scrutiny and that science would be judged free of conflicts of interest and hidden agendas. These commitments echoed his long‑standing critiques of perceived pharmaceutical influence, opacity in regulatory processes, and the alleged sidelining of alternative health approaches.
But according to The Lancet’s editorial — and a wide range of public health experts — most of those promises have not been fulfilled, and in many cases, the department appears to have moved in the opposite direction. The board accused Kennedy of destabilizing long‑established policies, sidelining independent experts, and introducing changes that contradict decades of scientific consensus. They argued that the erosion of institutional norms, suppression of stakeholder voices, and dismissal of expert advisers have collectively weakened the nation’s ability to protect public health.
A central point of contention surrounds Kennedy’s transformation of vaccine policy. Vaccines — long celebrated by public health authorities as one of the most effective tools for preventing disease — have been a flashpoint of criticism since his appointment. Within months of taking office, Kennedy’s HHS significantly restructured the Advisory Committee on Immunization Practices (ACIP), the expert panel that recommends vaccine schedules for Americans. In June 2025, all 17 sitting members — experts in immunology, pediatrics, and infectious disease — were removed. Kennedy’s team replaced them with a smaller group of hand‑picked individuals, many of whom have publicly expressed skepticism about established vaccine science.
This overhaul was justified by HHS as a necessary step to restore public trust and eliminate conflicts of interest. Kennedy has argued that long‑standing advisory systems favored industry interests over transparency and perceived safety concerns. However, former ACIP members and many independent scientists sharply disagree, warning that bypassing rigorous scientific review endangers public confidence and undermines the quality of policy decisions.
One dramatic example of the consequences of these changes was the revision of the childhood vaccine schedule. Under Kennedy’s leadership, several vaccines that had previously been universally recommended for children — including those for rotavirus, influenza, COVID‑19, meningococcal disease, and hepatitis A — were shifted into categories like “shared clinical decision‑making” or restricted to high‑risk populations. This change reduced the number of vaccines broadly recommended for all children, a shift that epidemiologists warn could create “pockets of susceptibility” and fuel outbreaks of preventable diseases. Critics have argued that this policy move was fashioned without the usual scientific vetting process, drawing comparisons to practices in countries with very different public health infrastructures, and prompting accusations that it substitutes ideology for evidence.
The controversy went beyond schedules: in May 2025, Kennedy unexpectedly rescinded CDC recommendations for COVID‑19 vaccines for healthy children and pregnant women, sidestepping the agency’s advisory committee process. This abrupt decision triggered immediate backlash from public health experts and medical societies, including the American College of Obstetricians and Gynecologists, who warned that the move ignored scientific evidence showing vaccine protection for vulnerable groups. Critics argued that the policy would reduce access to vaccines and possibly increase disease risk due to insurance coverage issues linked to CDC guidance.
In a separate legal development, a lawyer representing the U.S. Department of Justice argued in a federal court that Kennedy has “unreviewable” authority over vaccine policy decisions, implying that his actions — even those lacking clear scientific basis — could not be subjected to judicial oversight. The American Academy of Pediatrics and other medical groups have sued to block many of these policy changes, arguing that they were implemented without proper scientific justification or procedural transparency. The judge in the case expressed skepticism about the notion that such sweeping authority could be utterly immune from judicial review.
Beyond vaccines, The Lancet criticized actions across the health bureaucracy where scientific staff were dismissed, advisory processes throttled, and data transparency reduced. According to published accounts summarizing internal changes, HHS under Kennedy rescinded a decades‑old policy that required public comment on agency rulemaking, effectively eliminating a formal mechanism for stakeholders — including scientists, clinicians, and patient advocates — to provide input on major regulatory decisions. Critics saw this as a move toward centralizing decision‑making authority and reducing accountability.
These changes have not gone unnoticed by other public health institutions and former government officials. A coalition of former U.S. Surgeons General — including officials appointed by both Republican and Democratic administrations — issued their own warnings, characterizing some of Kennedy’s actions as “endangering the health of the nation.” They highlighted concerns such as weakened vaccine guidance, diminished disease surveillance capacity, and reallocation of research priorities away from well‑established scientific initiatives.
At the same time, Kennedy has championed other initiatives that appeal to certain segments of the public and medical community. For instance, he has pushed for expanded nutrition education in medical schools, arguing that dietary knowledge is critical to preventing chronic diseases. A significant number of U.S. medical schools agreed to increase nutrition training, a change that some experts view positively, though others caution that nutrition advocacy should complement, not replace, evidence‑based clinical science.
Despite these efforts, the broader picture presented by The Lancet and its critics is one of disruption — not just of specific policies, but of institutional norms that underpin public health governance. The editorial board expressed concern that dismantling long‑standing structures like ACIP, sidelining independent expertise, and overhauling scientific advisory processes could weaken the entire architecture of U.S. health protection. They warned that restoring public trust and operational integrity to agencies like CDC and NIH may require years or even generations of effort, a striking inversion of Kennedy’s original mandate to "restore trust" in these institutions.
Public trust has indeed become a measurable concern. Polling conducted in early 2026 showed declining confidence in federal health agencies’ leadership, with a substantial share of Americans saying they trust independent medical professional groups more than CDC, NIH, or FDA leaders. Many respondents expressed confusion or frustration over conflicting health guidance and policy shifts that appear to vacillate between conventional science and unorthodox positions.
The criticized policies have real‑world implications. The United States has experienced resurgent outbreaks of vaccine‑preventable diseases such as measles and other infections in recent years, which public health officials warn are exacerbated by lower vaccination coverage and public confusion. In the case of measles, outbreaks in 2025 and early 2026 were among the most severe in decades, with infections and hospitalizations disproportionately affecting unvaccinated children — outcomes that many epidemiologists argue could have been mitigated with consistent, evidence‑based vaccination recommendations.
Yet despite intense scrutiny and criticism, Kennedy has defended his leadership and decisions. He often frames his agenda as a rejection of what he calls “groupthink” and a return of agency authority to the American public rather than to industry or entrenched interests. His defenders argue that long‑standing public health institutions had become resistant to reform, and that questions about vaccine safety, pharmaceutical influence, and preventative health deserve open debate. These positions are controversial within the scientific community, where mainstream researchers overwhelmingly emphasize the safety and effectiveness of vaccines based on decades of rigorous research.
In response to The Lancet’s editorial, some commentators within scientific circles have pointed out the journal’s own contested history with vaccine research — including its publication of a now‑discredited paper in the late 1990s that initially suggested a link between the MMR vaccine and autism. That paper was later retracted and widely condemned by scientists because of serious methodological flaws. Nonetheless, the recent editorial’s core assertion remains rooted in a broader critique from public health experts: that policy decisions at HHS under Kennedy have too frequently departed from established scientific norms, with potential costs to population health.
In sum, the Lancet’s editorial — couched in unusually forceful language — reflects deep alarm within parts of the global medical community about the direction of U.S. public health leadership. Its claim that the “destruction” of a single year could take generations to repair underscores the perceived scale of institutional upheaval and the stakes involved when scientific consensus and governmental health policy appear to diverge. Whether Kennedy’s tenure ultimately reshapes American health policy for better or worse will be debated for years to come, but the editorial has already become a major milestone in that ongoing controversy.
Comments